title: Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction.
authors.affiliation: Quebec Heart Institute, Laval Hospital, Sainte-Foy.
authors.forename: Peter
authors.initials: P
authors.lastname: Bogaty
authors.forename: Christopher E
authors.initials: CE
authors.lastname: Buller
authors.forename: Paul
authors.initials: P
authors.lastname: Dorian
authors.forename: Blair J
authors.initials: BJ
authors.lastname: O'Neill
authors.forename: Paul W
authors.initials: PW
authors.lastname: Armstrong
mesh_terms: D016255:Anistreplase / Q000008:administration & dosage; D002170:Canada; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy*; D015425:Myocardial Reperfusion / Q000592:standards; D018570:Risk Assessment; D012720:Severity of Illness Index; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000592:standards*; D016896:Treatment Outcome
chemical_list: D016255:Anistreplase; D013300:Streptokinase